martes, 30 de junio de 2020

New FDA tool aims to inform cancer care, but experts warn of data gaps

New FDA tool aims to inform cancer care, but experts warn of data gaps

Cancer Briefing

A new FDA tool aims to inform cancer care, but experts say it has a glaring gap

By THERESA GAFFNEY


ADOBE
The platform gives cancer patients and physicians a way to comb through data on the experiences of clinical trial participants.

No hay comentarios: